What really happened at last night's EU Summit in Brussels - WATCH Euronews special show
ADVERTISEMENT
With a flurry of summits and special meeting being convened, what is the best way for leaders to chew over the big decisions?
Is the plan of EU High Representative Kaja Kallas to muster up to €40 billion in fresh military support for Ukraine up in smoke after leaders failed to endorse it during the EU Council Summit?
Now that Ursula von der Leyen's blueprint to mobilise up to €800 billion for defence over the next four years has been rebranded 'Readiness 2030', is the plan for a boost to the defence industry now open to wider infrastructure.
Following the EU Council summit which concluded on Friday, the former Commission President is our guest today, ready to chew over these questions.
Europe Today also brings you a special report from the summit floor, business news and a 'summit in numbers' feature.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
an hour ago
- Euronews
What is the level of public support for Israel in Western Europe?
A new YouGov study shows that the favourability towards Israel in Britain, France, Germany, Denmark, Spain and Italy is at or near its lowest level in Western Europe since 2016. The research interviewed 8,625 people from these six key Western European countries between November 2016 and May 2025. Net favourability towards Israel in Germany (-44), France (-48), and Denmark (-54) has reached its lowest level since YouGov started tracking in 2016, while public sentiment in Italy (-52) and Spain (-55) are likewise at their lowest or joint lowest levels, despite a shorter timespan from 2021 onwards. A number of Europeans across these six countries think Israel was right to send troops into Gaza, but believe they have since gone too far and caused too many civilian casualties. This opinion won the most support in Germany at 40%, followed by Denmark at 39% and Britain at 38%. Israel's military campaign has killed more than 54,000 Palestinians, mostly women and children, according to Gaza's Health Ministry. Food supplies have also been blocked, with the Integrated Food Security Phase Classification (IPC)'s latest report stating half a million people face starvation. Between 7% and 18% of European respondents say they sympathise most with the Israeli side, the lowest figure in most countries since the Hamas attacks. By contrast, between 18% and 33% say they sympathise more with the Palestinian side. Only in Germany are the figures for each side similar, with 17% for Israel and 18% for Palestine. Despite permanent peace in the Middle East seeming distant to Europeans, French people are the most optimistic that both sides will set aside their differences within the next 10 years. Meanwhile, Danes are the least optimistic at 15%. Across all countries, the opinion that peace is realistic has fallen in popularity by between four and ten percentage points. EU member states' representatives voted this week for retaliatory measures against Chinese restrictions on European medical device manufacturers, diplomatic and EU sources confirmed to Euronews. This followed an investigation by the European Commission found "clear evidence" that China unfairly blocked EU-made medical devices from its procurement market. It represents the first countermeasure implemented using an International Procurement Instrument (IPI), which came into force in August 2022, designed to ensure fair access for EU firms to procurement opportunities outside the bloc. Ambassadors adopted the proposal midweek, but the details are expected to be published in the EU's Official Journal in the coming days. 'We had truly hoped that the International Procurement Instrument process would lead to more meaningful dialogue and progress with China, but unfortunately, that hasn't happened yet,' said Oliver Bisazza, CEO of MedTech Europe, the EU's association of medical device manufacturers. Bisazza wants to see the full details before reacting, but he pointed out that medical device companies remain committed to constructive engagement between the EU and China. 'This sector is vital for saving and improving people's lives and maintaining essential healthcare infrastructure, offering crucial services. This is something both parties should consider,' he added. EU companies have long struggled to gain access to China's public procurement market, despite China being one of Europe's largest trading partners for medical devices - accounting for 11% of export destinations in 2022. The Commission's investigation focused on China's government procurement law, which enforces the so-called "Buy China" policy, requiring public entities to prioritise domestic products and services, with limited exceptions. The probe found that EU manufacturers face a range of obstacles, including opaque approval systems, discriminatory certification procedures, vague national interest clauses used to exclude foreign bidders, and pricing pressures that are often unfeasible for European firms. One stark example: in Guangdong Province, the number of 'approved' imported medical devices dropped from 132 in 2019 to just 46 in 2021, highlighting the tightening of market access for EU firms. The China Chamber of Commerce to the EU responded with concern, tweeting that the IPI measures send 'a troubling signal' for bilateral trade ties. In a follow-up statement, the Chamber argued that the targeted use of the IPI risks becoming a de facto trade barrier and urged the EU to reconsider the necessity and long-term impact of such actions. The measures come at a sensitive moment in EU-China relations, which are currently undergoing a tentative diplomatic reset. After years of friction, the two sides have stepped up engagement to manage long-standing disputes. Much of this renewed dialogue is a response to shifting global dynamics, including the Trump-era trade war and broader US-China tensions, which have prompted Brussels to pursue a more balanced approach. A key milestone in this reset is the upcoming EU-China Summit, now confirmed to take place in Beijing in the second half of July 2025. Despite the escalating procurement dispute, a Commission spokesperson downplayed concerns that the IPI measures would damage broader trade relations. 'We've been making very clear to any global partners with whom we believe there is a problem as regards to the level playing field for procurement: should those problems not be removed, we would be forced to take action,' said the spokesperson. On Wednesday, EU Trade Commissioner Maroš Šefčovič met with Chinese Minister Wang Wentao on the sidelines of the OECD Ministerial Council – their third meeting overall and second in person. According to the Commission, the talks covered a wide range of critical bilateral issues as both sides work to ensure progress ahead of the July summit.
Euronews
an hour ago
- Euronews
EU hits back against 'Buy China' policy in medical devices market
EU member states' representatives voted this week for retaliatory measures against Chinese restrictions on European medical device manufacturers, diplomatic and EU sources confirmed to Euronews. This followed an investigation by the European Commission found "clear evidence" that China unfairly blocked EU-made medical devices from its procurement market. It represents the first countermeasure implemented using an International Procurement Instrument (IPI), which came into force in August 2022, designed to ensure fair access for EU firms to procurement opportunities outside the bloc. Ambassadors adopted the proposal midweek, but the details are expected to be published in the EU's Official Journal in the coming days. 'We had truly hoped that the International Procurement Instrument process would lead to more meaningful dialogue and progress with China, but unfortunately, that hasn't happened yet,' said Oliver Bisazza, CEO of MedTech Europe, the EU's association of medical device manufacturers. Bisazza wants to see the full details before reacting, but he pointed out that medical device companies remain committed to constructive engagement between the EU and China. 'This sector is vital for saving and improving people's lives and maintaining essential healthcare infrastructure, offering crucial services. This is something both parties should consider,' he added. EU companies have long struggled to gain access to China's public procurement market, despite China being one of Europe's largest trading partners for medical devices - accounting for 11% of export destinations in 2022. The Commission's investigation focused on China's government procurement law, which enforces the so-called "Buy China" policy, requiring public entities to prioritise domestic products and services, with limited exceptions. The probe found that EU manufacturers face a range of obstacles, including opaque approval systems, discriminatory certification procedures, vague national interest clauses used to exclude foreign bidders, and pricing pressures that are often unfeasible for European firms. One stark example: in Guangdong Province, the number of 'approved' imported medical devices dropped from 132 in 2019 to just 46 in 2021, highlighting the tightening of market access for EU firms. The China Chamber of Commerce to the EU responded with concern, tweeting that the IPI measures send 'a troubling signal' for bilateral trade ties. In a follow-up statement, the Chamber argued that the targeted use of the IPI risks becoming a de facto trade barrier and urged the EU to reconsider the necessity and long-term impact of such actions. The measures come at a sensitive moment in EU-China relations, which are currently undergoing a tentative diplomatic reset. After years of friction, the two sides have stepped up engagement to manage long-standing disputes. Much of this renewed dialogue is a response to shifting global dynamics, including the Trump-era trade war and broader US-China tensions, which have prompted Brussels to pursue a more balanced approach. A key milestone in this reset is the upcoming EU-China Summit, now confirmed to take place in Beijing in the second half of July 2025. Despite the escalating procurement dispute, a Commission spokesperson downplayed concerns that the IPI measures would damage broader trade relations. 'We've been making very clear to any global partners with whom we believe there is a problem as regards to the level playing field for procurement: should those problems not be removed, we would be forced to take action,' said the spokesperson. On Wednesday, EU Trade Commissioner Maroš Šefčovič met with Chinese Minister Wang Wentao on the sidelines of the OECD Ministerial Council – their third meeting overall and second in person. According to the Commission, the talks covered a wide range of critical bilateral issues as both sides work to ensure progress ahead of the July summit.
France 24
an hour ago
- France 24
Musk 'very welcome' in Europe after Trump bust-up, official says
The Trump-Musk political marriage blew up on Thursday as the president declared himself "very disappointed" in criticisms from his former aide and top donor -- before the pair hurled insults at each other on social media. At the commission's daily briefing, spokesperson Paula Pinho was asked whether Musk had reached out to the European Union with a view to relocating his businesses, or setting up new ones. "He's very welcome," she replied with a smile. The commission's spokesperson for tech matters, Thomas Regnier, followed up by stressing -- straight-faced -- that "everyone is very welcome indeed to start and to scale in the EU". "That is precisely the objective of Choose Europe," he said, referencing an EU initiative in favour of start-ups and expanding businesses. Musk has been a frequent critic of the 27-nation EU -- attacking its digital laws as censorship and berating its leaders, while cheering on the ascendant far-right in Germany and elsewhere. The tycoon's row with Trump saw the president threaten to strip him of government contracts estimated at $18 billion -- with Musk vowing in response to end a critical US spaceship programme. Explaining the rift, Trump said Musk had gone "crazy" about a plan to end electric vehicle subsidies in the new US spending bill -- as the bust-up sent shares in Musk's Tesla car company plunging.
